When the emotional-contagion study was published in PNAS in June 2014, the reaction was not mainly about its findings - the effects on users’ word choice were tiny - but about the fact that Facebook had manipulated 689,003 people’s News Feeds for a week to study their moods, and that none of them had been asked. The public response was swift and angry, and the episode became a defining moment in the debate over how platforms experiment on their users.
Part of what made the case awkward is that platforms run experiments on their feeds constantly. A/B testing - showing different versions of a product to different users to see which performs better - is standard practice, and tuning the feed is exactly what that work involves. What changed the situation was the act of writing it up as published science with a university co-author, which brought it under the norms of academic human-subjects research, including informed consent and ethical review. PNAS itself acknowledged the tension, issuing an Editorial Expression of Concern that the data collection may not have followed those principles, while noting Facebook was not bound by the same rules as university researchers.
The controversy hardened a distinction that still matters: the same feed manipulation can be unremarkable as product optimization and a scandal as research, depending on framing and oversight. It also pushed companies and academics to develop clearer norms for studying users, and it became a frequently cited example in later arguments for algorithmic transparency.
Why business readers should care: the lesson is less “do not experiment on users” - everyone does - and more that consent, disclosure, and the context in which results are presented determine whether routine optimization reads as responsible or as a violation.